PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study: Autophagy predicts which cancer cells live and die when faced with anti-cancer drugs

2014-01-11
(Press-News.org) Contact information: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Study: Autophagy predicts which cancer cells live and die when faced with anti-cancer drugs When a tumor is treated with an anti-cancer drug, some cells die and, unfortunately, some cells tend to live. A University of Colorado Cancer Center study published in the journal Nature Cell Biology details a possible difference between the susceptible and resistant cells: the rate at which cells are able to cleanse themselves via the process known as autophagy.

"In these studies, say we treat cells with the IC-50 of a drug - at that dose, 50 percent of cells should live and 50 percent of cells should die. But the fundamental question is why does cell A die whereas cell B lives? What we show is that the difference may be due to random variation in the amount of autophagy that's going on," says Andrew Thorburn, PhD, deputy director of the CU Cancer Center.

Previous studies show that autophagy promotes cell survival – under conditions of stress or shortage, cells break down non-necessary components to provide energy or use the same strategy to prevent cellular damage by degrading and recycling potentially damaging proteins. And so it seems logical that cancer cells with low autophagy would have high mortality when faced with anti-cancer drugs. However, the current study shows that rates of cell death may increase or decrease depending on levels of autophagy and the specific mechanism of the anti-cancer drug.

"We separated cancer cells into populations with low and high autophagy and then treated them with two drugs, both of which should activate death. Interestingly, when treated with the first drug, cells with high autophagy had the highest mortality. But then when treated with the second drug, cells with low autophagy had the highest mortality. Depending on the drug, the effect of autophagy was opposite," Thorburn says.

Specifically, Thorburn and colleagues including first author Jacob Gump, PhD, treated high- and low-autophagy cell populations with chemicals TRAIL and Fas ligand, which activate cells' death receptors. Cells treated with these chemicals are "told" to die and as the researchers expected, some cells in all populations underwent the programmed cell death known as apoptosis. However, cells with high autophagy were more sensitive to treatment with Fas ligand, whereas cells with low autophagy were more sensitive to TRAIL. Similar differences were seen across types of cancer cells - in some cancers, autophagy protects against these drugs and in others autophagy makes cells more susceptible.

While the work does not necessarily add to our understanding of how autophagy aids cell survival, the group showed how it creates cell death in some tumors when confronted with some drugs: a protein known as FAP-1 is present in some but not all cancer cells where it serves to decrease the ability of Fas ligand to kill the cells. Autophagy degrades this cell-survival protein and this, in turn, makes cells more susceptible to Fas ligand but only in the cells where FAP-1 is normally present.

"If similar variation occurs in other contexts, a cancer cell you're trying to kill could be more or less resistant to whatever you're using to try to kill it depending on its level of autophagy," Thorburn says. Additionally, Thorburn points out that cells in these lab studies tend to be homogenous in their levels of autophagy compared to cells in natural tumor environments. It is likely, he says, these laboratory results will be magnified in actual tumors, where levels of autophagy tend to vary more widely.

While Fas ligand and TRAIL agonists are used in the lab only at this time, Thorburn says the next step in this line of research is to perform similar experiments with drugs that could be used in people.

### END


ELSE PRESS RELEASES FROM THIS DATE:

Text messaging boosts flu vaccine rates in pregnant women

2014-01-11
Text messaging boosts flu vaccine rates in pregnant women January 10, 2014 --A study by researchers at the Mailman School of Public Health evaluated the impact of text messaging reminders for influenza vaccine in a low-income obstetric ...

Complementary medicine in wide use to treat children with autism, developmental delay

2014-01-11
Complementary medicine in wide use to treat children with autism, developmental delay

Study shows large carnivore numbers and range declining worldwide

2014-01-10
Study shows large carnivore numbers and range declining worldwide MISSOULA – New research co-written by University of Montana scientists finds steep declines in the worldwide populations and habitat range of 31 large carnivore species. The analysis, ...

Harvard scientists control cells following transplantation, from the inside out

2014-01-10
Harvard scientists control cells following transplantation, from the inside out New work by Jeffrey Karp, Ph.D., has potential to make cell therapies more functional and efficient Harvard stem cells scientists at Brigham and Women's Hospital and MIT can now engineer ...

Indigenous groups more vulnerable in the fight against flu

2014-01-10
Indigenous groups more vulnerable in the fight against flu Research indicated that some Indigenous people such as in Alaska and Australia displayed limited immunity response to the effects of influenza. Published in the Journal Proceedings of the National ...

Living on islands makes animals tamer

2014-01-10
Living on islands makes animals tamer Study confirms Darwin's observations and numerous anecdotal reports of island tameness, says UC Riverside's Theodore Garland RIVERSIDE, Calif. — Most of us have seen pictures and probably YouTube videos of "tame" animals ...

Evidence of harmful effect of bisphenol A-based plastics

2014-01-10
Evidence of harmful effect of bisphenol A-based plastics Function and regeneration of switch proteins impaired Bisphenol A impairs the function of proteins that are vital for growth processes in cells. This finding has been reported by researchers from the ...

Regorafenib: hint of minor added benefit

2014-01-10
Regorafenib: hint of minor added benefit Advantage in overall survival, but disadvantage in severe side effects Regorafenib (trade name: Stivarga) has been approved in Germany since August 2013 for adults with metastatic colorectal ...

KIT researchers develop artificial bone marrow

2014-01-10
KIT researchers develop artificial bone marrow This news release is available in German. Artificial bone marrow may be used to reproduce hematopoietic stem cells. A prototype has now been developed by scientists of KIT, the Max Planck Institute for Intelligent ...

Study quantifies costs when failed banks shun financial transparency

2014-01-10
Study quantifies costs when failed banks shun financial transparency New study shows that more transparent accounting helps bidders, lowers costs when financial institutions fail Good accounting isn't just a hallmark of a well-run company: As a new study ...

LAST 30 PRESS RELEASES:

Scientists trace origins of now extinct plant population from volcanically active Nishinoshima

AI algorithm based on routine mammogram + age can predict women’s major cardiovascular disease risk

New hurdle seen to prostate screening: primary-care docs

MSU researchers explore how virtual sports aid mental health

Working together, cells extend their senses

Cheese fungi help unlock secrets of evolution

Researchers find brain region that fuels compulsive drinking

Mental health effects of exposure to firearm violence persist long after direct exposure

Research identifies immune response that controls Oropouche infection and prevents neurological damage

University of Cincinnati, Kent State University awarded $3M by NSF to share research resources

Ancient DNA reveals deeply complex Mastodon family and repeated migrations driven by climate change

Measuring the quantum W state

Researchers find a way to use antibodies to direct T cells to kill Cytomegalovirus-infected cells

Engineers create mini microscope for real-time brain imaging

Funding for training and research in biological complexity

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: September 12, 2025

ISSCR statement on the scientific and therapeutic value of human fetal tissue research

Novel PET tracer detects synaptic changes in spinal cord and brain after spinal cord injury

Wiley advances Knowitall Solutions with new trendfinder application for user-friendly chemometric analysis and additional enhancements to analytical workflows

Benchmark study tracks trends in dog behavior

OpenAI, DeepSeek, and Google vary widely in identifying hate speech

Research spotlight: Study identifies a surprising new treatment target for chronic limb threatening ischemia

Childhood loneliness and cognitive decline and dementia risk in middle-aged and older adults

Parental diseases of despair and suicidal events in their children

Acupuncture for chronic low back pain in older adults

Acupuncture treatment improves disabling effects of chronic low back pain in older adults

How interstellar objects similar to 3I/ATLAS could jump-start planet formation around infant stars

Rented e-bicycles more dangerous than e-scooters in cities

Ditches as waterways: Managing ‘ditch-scapes’ to strengthen communities and the environment

In-situ molecular passivation enables pure-blue perovskite LEDs via vacuum thermal evaporation

[Press-News.org] Study: Autophagy predicts which cancer cells live and die when faced with anti-cancer drugs